Report: High Drug Prices Could Threaten Access to Coronavirus Treatments
Pharmaceutical companies' high pricing could threaten access to potential COVID-19 treatments, The Guardian reports. Sofosbuvir, a hepatitis C drug, costs [...]
Panel Discusses Opportunity Costs, Innovative Drugs
A recent panel during Virtual ISPOR 2020 discussed how payers grapple with opportunity costs as innovative therapies hit the market. [...]
How is the QALY Performing Amid a Pandemic?
Going Below the Surface in a recent newsletter considers how the quality-adjusted life year (QALY) is holding up amid COVID-19. [...]
Value-Based vs. Fee-for-Service in the World of COVID-19
Will the COVID-19 pandemic mark a new push toward value-based payments over a fee-for-service model? Eric Weaver, executive director of [...]
Inovalon Launches New Solution to Streamline Health Plans’ Compliance with Patient Access API
Inovalon announced the launch of the Consumer Health Gateway, a new online solution aimed at helping health plans fall into [...]
Will Expanded Access to Telehealth Services Stay Put?
While the Trump administration's sweeping reimbursement changes led to expanded telehealth services and access, some are concerned about their longevity, [...]
Webinar to Outline Clinical Use Cases for Pharmacogenomic Results
The Journal of Precision Medicine and the Precision Medicine Leaders' Summits is hosting a free webinar on clinical use cases [...]
PRMA’s Lodowski Highlights 2020 Updates to ICER’s Value Assessment Framework
PRMA Consulting's Nicole Lodowski in a recent blog post outlines seven key areas that have been updated in the Institute [...]
cOAlition S Updates Criteria for Transformative Journals
cOAlition S has updated its framework guiding transformative journals to open access, The Publication Plan reports. Among the changes, cOAlition [...]
Research Finds Lower Care Costs with Increased Use of New Drugs for Treatment of Pancreatic Cancer Patients
The results of a new study by Tyme Technologies, Inc., suggests the increased use of novel drugs in the treatment [...]
ICER Posts Report Outlining Planned Review of Supervised Injection Facilities
The Institute for Clinical and Economic Review (ICER) posted a new document outlining a planned review of supervised injection facilities [...]
Bringing Value-Based Care into Oncology Landscape
Brillstein Collaborative Consulting CEO Lili Brillstein in a recent interview with AJMC discusses the challenges of bringing value-based care in [...]
Garrison, Howard Discuss Future of Value Assessment
The American Journal of Managed Care (AMJC) recently interviewed two panelists set to discuss the future of value assessment during [...]
Study Finds ‘Moderate Agreement’ of Bias Assessment Using Data- and Opinion-Based Methods
A recent study suggests there's "moderate agreement" between opinion- and data-based assessments of bias in randomized trials. The study was [...]
How Payers are Bolstering Access to COVID-19 Care
A recent article by HealthPayerIntelligence takes a look at how the 10 largest payers in the U.S. are tackling care [...]
Inovalon Launches New Platform to Inform COVID-19 Action
Inovalon announced the launch of a new platform aimed at delivering data-driven insights to inform COVID-19 response plans. The Population [...]
J&J’s Lewi Talks RWD
Johnson & Johnson's Martine Lewi during the 9th DPharm: Disruptive Innovations conference discussed the company's use of real-world data in [...]
How COVID-19 is Impacting Payer Utilization of Tech
HealthPayerIntelligence in a recent article looks at how the COVID-19 pandemic is changing how payers are using technology to navigate [...]
Initiative Aims to Reduce Social Isolation Amid Social Distancing
A new initiative led by Papa aims to spread awareness about the risks associated with loneliness in the world of [...]
CCPM, RGC Partner on Precision Medicine, Drug Discovery
The Colorado Center for Personalized Medicine (CCPM) and Regeneron Genetics Center (RGC) announced a new partnership aimed at using genomic [...]
Registries to Bolster Understanding of COVID-19’s Impact on Patients with Heart Disease
The American College of Cardiology (ACC) will begin collecting data through the Chest Pain - MI Registry and CathPCI Registry [...]
Kling Talks Digital Endpoint for Parkinson’s Disease
Sanofi Director of Digital Innovation Laura Kling during the 9th DPharm: Disruptive Innovations Conference discussed the development of a digital [...]
BIO Taps Former FDA Official as New President, CEO
The Biotechnology Innovation Organization recently appointed former Food and Drug Administration (FDA) official Michelle McMurry-Heath as its new president and [...]
Judge Denies Shkreli’s Request for Release
A judge denied Martin Shkreli's request to be released from prison to help in the fight against COVID-19, pharmaphorum reports. [...]
Putting a Dollar Amount on Human Life
Austin Frakt in a recent article published in the New York Times outlines how governments have tackled the issue of [...]